skip to Main Content
New York Estimates That Half of Eligible Patients Received Medical Marijuana

ALBANY — Nearly three months into the launch of the state’s medical marijuana program, the Cuomo administration estimates that roughly half of the patients deemed eligible have received the drug, a Department of Health spokesman told POLITICO New York.

The so-called Compassionate Care Act kicked off in early January with several dispensaries not opening in time for the launch date. But the registered organizations charged with growing and selling medical marijuana say they were expecting the trickle of customers to start, rather than a flood, and that they are now seeing an increasing number of patients.

Since early January, the state estimates 2,039 patients have been certified by their doctors to be eligible for medical marijuana. About 1,000 of those patients, according to the Department of Health, have obtained the drug.

But even as the access seems to improve for those who qualify for the program, advocates, as well as the lawmakers who sponsored the initial medical marijuana legislation, continue to argue patients struggle unnecessarily to find doctors who can prescribe the drug. [Read more at Politico]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…

Tech glitch on 4/20 caused Missouri cannabis businesses to lose sales

April 20 is a day recognized globally for celebrating cannabis culture, but it’s also like the cannabis industry’s Black Friday. Dispensaries offer deals designed to inspire people to flood their stores…

Japan’s cannabis market growing rapidly amid regulatory shift

Japan’s cannabis market expanded sixfold over four years to ¥24 billion ($154 million) in 2023, a trend that is expected to accelerate with the amendment in December of cannabis laws,…

Ispire Leads with a Focus on Safety and Innovation

Los Angeles-based Ispire Technologies (NASDAQ: ISPR) is a three-year-old company built on the foundation (and reputation) of a global enterprise with many years of experience as an ODM (original design…

More Categories

Back To Top
×Close search
Search